PharmaChk: a decade of research and development towards the first quantitative, field-based medicine quality screening instrument-Reference-Cited by-同舟云学术

PharmaChk: a decade of research and development towards the first quantitative, field-based medicine quality screening instrument

Published:2022 Issue:17 Volume:147 Page:3805-3816
ISSN:0003-2654
Container-title:The Analyst
language:en
Short-container-title:Analyst

Author:

Acevedo Andrew J.¹²^ORCID,Desai Darash³,Zaman Muhammad H.³⁴,Apiou-Sbirlea Gabriela¹²⁵

Affiliation:

1. Department of Dermatology, Harvard Medical School, Harvard University, 02115, Boston, MA, USA

2. Mass General Research Institute, Massachusetts General Hospital, 02114, Boston, MA, USA

3. Department of Biomedical Engineering, Boston University, Boston, MA, USA

4. Howard Hughes Medical Institute, Boston University, Boston, MA, USA

5. Wellman Center for Photomedicine, Massachusetts General Hospital, 02114, Boston, MA, USA

Abstract

We describe the scientific, engineering work over the first ten years of PharmaChk, the first quantitative, portable instrument for medicine quality screening, to illustrate what it takes for academic labs to translate observations into interventions.

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/AN/D2AN00284A

Reference53 articles.

1. Anatomy and physiology of translation: the academic research imperative

2. Biomedical optics centers: forty years of multidisciplinary clinical translation for improving human health

3. Sensing, monitoring, and release of therapeutics: the translational journey of next generation bandages

4. In vivo optical endomicroscopy: two decades of translational research towards next generation diagnosis of eosinophilic esophagitis

5. Impact of poor-quality medicines in the ‘developing’ world